Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. (Q54536554)

31 May 2018

title

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. (English)

1 reference

31 May 2018

1 reference

Ida Ricciardelli

1

1 reference

31 May 2018

Keith J Lindley

series ordinal

2

1 reference

31 May 2018

Marco Londei

series ordinal

3

1 reference

31 May 2018

Sonia Quaratino

series ordinal

4

1 reference

31 May 2018

publication date

16 April 2008

1 reference

31 May 2018

published in

Immunology

1 reference

31 May 2018

volume

125

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

178-183

1 reference

31 May 2018

Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Phenotypic and functional features of human Th17 cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Cytokine therapy for Crohn's disease: advances in translational research

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Mechanisms of suppression by suppressor T cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Control of regulatory T cell development by the transcription factor Foxp3

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

The TNF and TNF receptor superfamilies: integrating mammalian biology

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Tumor necrosis factor: biology and therapeutic inhibitors

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2561134

Anti-TNF Therapy for Crohnʼs Disease: A Perspective (Infliximab Is Not the Drug We Have Been Waiting For)

2 November 2018

1 reference

12 December 2020

FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease

1 reference

12 December 2020

Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts

1 reference

12 December 2020

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

12 December 2020

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease

1 reference

12 December 2020

10.1111/J.1365-2567.2008.02839.X

Identifiers

DOI

1 reference

31 May 2018

PMC publication ID

2561134

0 references

1 reference

31 May 2018